ADJUVANT AUTOLOGOUS INTRAVESICAL MACROPHAGE CELL THERAPY VS. BCG FOR NON-MUSCLE INVASIVE BLADDER CANCER: A PHASE II, MULTICENTER, RANDOMIZED TRIAL

被引：0
|
作者：
Burger, M. [1 ]
Thiounn, N. [2 ]
Denzinger, N. [1 ]
Malavaud, B. [3 ]
Wirth, M. [4 ]
Thueroff, J. W. [5 ]
Romics, I. [6 ]
Colombel, M. [7 ]
Solsona, E. [8 ]
Tombal, B. [9 ]
Sherman, J. [10 ]
机构：
[1] Univ Regensburg, Dept Urol, Regensburg, Germany
[2] Univ Paris 05, Dept Urol, Paris, France
[3] Paris St Joseph Hosp Trust, Dept Urol, Paris, France
[4] Univ Dresden, Dept Urol, Dresden, Germany
[5] Johannes Gutenberg Univ Mainz, Dept Urol, Mainz, Germany
[6] Semmelweis Univ, Dept Urol, H-1085 Budapest, Hungary
[7] Hop Edouard Herriot, Dept Urol, Lyon, France
[8] Inst Valenciano Oncol, Dept Urol, Valencia, Spain
[9] Clin Univ St Luc, Dept Urol, B-1200 Brussels, Belgium
[10] IDM Pharma, Dept Med, Irvine, CA USA
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1569-9056(09)60652-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [1] The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial
    Maximilian Burger
    Nicolas Thiounn
    Stefan Denzinger
    Jozsef Kondas
    Gerard Benoit
    Manuel S Chapado
    Fernando J Jimenz-Cruz
    Laszlo Kisbenedek
    Zoltán Szabo
    Domján Zsolt
    Marc O Grimm
    Imre Romics
    Joachim W Thüroff
    Tamas Kiss
    Bertrand Tombal
    Manfred Wirth
    Marc Munsell
    Bonnie Mills
    Tung Koh
    Jeff Sherman
    Journal of Translational Medicine, 8
  • [2] The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial
    Burger, Maximilian
    Thiounn, Nicolas
    Denzinger, Stefan
    Kondas, Jozsef
    Benoit, Gerard
    Chapado, Manuel S.
    Jimenz-Cruz, Fernando J.
    Kisbenedek, Laszlo
    Szabo, Zoltan
    Zsolt, Domjan
    Grimm, Marc O.
    Romics, Imre
    Thueroff, Joachim W.
    Kiss, Tamas
    Tombal, Bertrand
    Wirth, Manfred
    Munsell, Marc
    Mills, Bonnie
    Koh, Tung
    Sherman, Jeff
    JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
  • [3] Intravesical BCG therapy for non-muscle invasive bladder cancer
    Figurin, K. M.
    ONKOUROLOGIYA, 2012, 8 (01): : 14 - 22
  • [4] ADJUVANT CANCER PEPTIDE VACCINE TREATMENT WITH INTRAVESICAL BCG THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER
    Obara, Wataru
    Hara, Isao
    Miki, Tsuneharu
    Mimata, Hiromitsu
    Shuin, Taro
    Fujioka, Tomoaki
    JOURNAL OF UROLOGY, 2014, 191 (04): : E570 - E570
  • [5] Phase II trial of BC-819 intravesical gene therapy in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC).
    Halachmi, Sarel
    Leibovitch, Ilan
    Zisman, Amnon
    Stein, Avi
    Benjamin, Shalva
    Sidi, Ami
    Knickerbocker, Ron
    Limor, Michal
    Moore, Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [6] Phase II trial of intravesical camrelizumab in BCG-unresponsive high-risk non-muscle invasive bladder cancer
    Shen, Yijun
    Peng, Liangju
    Xu, Peihang
    Wang, Yanhao
    Wang, Xiang
    Yao Xudong
    Liu, Yushan
    Ye, Ding-Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [7] Compared Efficacy of Adjuvant Intravesical BCG TICE vs. RIVM for High-risk Non-muscle Invasive Bladder Cancer: A Multicenter Propensity Score Matched Analysis
    Del Giudice, F.
    Flammia, S.
    Sciarra, A.
    Salciccia, S.
    Maggi, M.
    Canale, V
    Viscuso, P.
    Moriconi, M.
    Busetto, G. M.
    Falagario, U.
    Carrieri, G.
    Cormio, L.
    Skinner, E. C.
    Chung, B., I
    De Berardinis, E.
    EUROPEAN UROLOGY, 2022, 81 : S253 - S255
  • [8] A randomized study to compare outcomes of intravesical chemohyperthermia with mitomycin c vs. intravesical BCG for intermediate and high risk Non-Muscle Invasive Bladder Cancer (NMIBC)
    Guleria, K.
    Sood, R.
    Goel, H.
    Gahlawat, S.
    Sharma, U.
    Singla, A.
    Masood, P. F.
    Kabra, S.
    Singh, R.
    EUROPEAN UROLOGY, 2022, 81 : S370 - S370
  • [9] IS INTRAVESICAL BCG ALONE STILL THE ONLY TRULY EFFECTIVE INTRAVESICAL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER?
    Di Stasi, Savino Mauro
    Riedl, Claus
    Giannantoni, Antonella
    Verri, Cristian
    Celestino, Francesco
    De Carlo, Francesco
    Masedu, Francesco
    Valenti, Marco
    JOURNAL OF UROLOGY, 2015, 193 (04): : E381 - E381
  • [10] Current intravesical therapy for non-muscle invasive bladder cancer
    van Lingen, Anna V.
    Witjes, J. Alfred
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (10) : 1371 - 1385
12345